SAT Hospital in Keralam rejects charges of ‘clinical trial drugs’ given to SMA-afflicted children
SAT Hospital in Kerala has denied allegations that it used experimental 'clinical trial drugs' on children suffering from spinal muscular atrophy. The hospital superintendent stated that a technical committee approved the use of a generic, cost-effective version of the medication to ensure broader patient access.
Why it matters
The controversy highlights the tension between public health efforts to provide affordable rare disease treatments and political scrutiny regarding medical ethics and regulatory compliance.
SAT Hospital in Keralam rejects charges of ‘clinical trial drugs’ given to SMA-afflicted children left SAT Hospital in Thiruvananthapuram. https://th-i.thgim.com/public/incoming/705fo/article71612966.ece/alternates/FREE_1200/SAT%20Hospital.jpg TH SAT Hospital Hospital Superintendent says decision to provide SMA patients with a less expensive, generic version of the original molecule against SMA, in place of the imported original drug costing several lakhs of rupees for a single vial, was taken by a technical committee comprising experts in the field Thiruvananthapuram SAT Hospital in Thiruvananthapuram, Keralam, the premier tertiary-level child health institution in the State’s public sector and one of the chosen Centres of Excellence for Rare Diseases in the country, has found itself in the eye of the storm following allegations about “clinical trial drugs” being given to spinal muscular atrophy (SMA)-afflicted children. With Opposition political parties intent on carrying forth with the campaign that “experimental drugs” were used on SMA patients, the Superintendent of SAT Hospital, I.
Get smarter about the news
Sign up free for a feed built around what you actually care about, Dive Deeper research on any story, and the full text of every article.
Create free accountAlready have an account? Sign in